content top

Treatment of Full Thickness Macular Hole with ILM Peeling and Different Densities of Silicone Oil Tamponade

Advantages: A high macular hole closure rate is obtained, and late reopening of the hole is avoided. Methods: In a prospective randomized trial, 72 eyes of 71 patients underwent vitrectomy with ILM peeling after staining with ILM-Blue to treat full-thickness macular hole. Two treatment arms were used: either 2000 cs or 5000 cs silicone oil was used, which was removed after 3 months. During the second procedure, half of the eyes of each...

Read More

Novel Technical Developments to Improve Surgical Safety During Phaco-Vitrectomy for Retinal Detachment

Peter Stalmans (Leuven, Belgium) Purpose: During surgery, several complications can occur: posterior lens capsule aspiration, aspiration of retinal tissue into the cutter during vitreous base shaving and pressure alterations leading to hypotony (inducing collaps and even subchoroidal haemmorrhage) or hypertony (compromising the retinal perfusion). Methods: Several soft and hardware features were developed for the Dual Associate device...

Read More

A Single Injection of Ocriplasmin for the Treatment of Symptomatic Vitreomacular Adhesion (sVMA): Results of the Phase III MIVI-TRUST Program

Peter Stalmans for the MIVI-TRUST Study Group (Leuven, Belgium) Purpose: Symptomatic vitreomacular adhesion (sVMA) is implicated in the pathobiology of retinal disorders including vitreomacular traction syndrome and macular hole, and is associated with more severe disease in other conditions such as diabetic retinopathy, DME, and AMD. The MIVI-TRUST program is composed of two Phase III trials evaluating ocriplasmin for the treatment of sVMA...

Read More

Recovery of Macular Anatomy after Release of Vitreo Macular Adhesion Using Microplasmin

http://www.evrs.eu/medias/2010/videos/PeterStalmans_VP6_768K.flv Peter Stalmans (Leuven, Belgium) Advantages: Vitreo macular adhesion can cause significant distortion of the normal macular anatomy, resulting in decreased visual function, and can lead to macular hole formation, or enhance other diseases such as diabetic maculopathy or age related macular degeneration. Release of the vitreo macular adhesion can restore the macular anatomy,...

Read More

Treating Stage 1 Macular Hole without Surgery by Injecting Microplasmin

http://www.evrs.eu/medias/2009/congress/Is-ILM-Peeling-Mandatory.flv Author: Peter Stalmans, Meive, Belgium Advantages: Vitrectomy for vitreomacular traction/early stage macular holes has inherent disadvantages and risks, and induces increased patient morbidity. Methods: A phase II randomized, double-masked clinical trial with control sham injection in patients with vitreomacular traction was designed. Patients in each of four cohorts...

Read More

Pharmacological Release of Vitreomacular Traction Using

http://www.evrs.eu/medias/2008/congress/Pharmacological-Release-of-Vitreomacular-Traction-Using.flv Peter Stalmans, Marc De Smet, Christophe Delaey Advantages: Vitreomacular traction (VMT) with decreased visual function is a common indication to perform a vitrectomy. Pharmacologic release of the traction from the fovea may omit the need to perform a vitrectomy in these cases. Methods: Patients were included in a phase II randomized...

Read More

Expression of VEGF and PEDF in Choroidal Neovascular Membranes Following Verteporfin Photodynamic Therapy

Olcay Tatar, (Tuebingen, Germany), Annemarie Adam, (Tuebingen, Germany), Kei Shinoda, MD, PhD (Tokyo, Japan), Peter Stalmans, MD, PhD (Leuven, Belgium), Claus Eckardt, MD (Frankfurt, Germany), Matthias Lu╠łke, MD (Tuebingen, Germany), Karl Ulrich Bartz-Schmidt (Tuebingen, Germany), Salvatore Grisanti, MD (Tuebingen, Germany) PURPOSE: To examine the impact of photodynamic therapy (PDT) on pigment epithelium derived factor (PEDF) expression...

Read More

Expression of VEGF and Endostatin in Human Choroidal Neovascular Membranes Following Verteporfin Photodynamic Therapy

Salvatore Grisanti, MD (Tuebingen, Germany), Olcay Tatar, MD (Tuebingen, Germany), Kei Shinoda, MD, PhD (Tokyo, Japan), Annemarie Adam, (Tuebingen, Germany), Klaus Lucke, MB ChB (Bremen, Germany), Claus Eckardt, MD (Frankfurt, Germany), Peter Stalmans, MD, PhD (Leuven, Belgium), Tillmann Eckert, MD (Frankfurt, Germany), Silvia Bopp, MD (Bremen, Germany), Karl Ulrich Bartz-Schmidt (Tuebingen, Germany) PURPOSE: To evaluate the impact of...

Read More

Choice of IOl and Pitfalls in Combined Phaco-Vitrectomy

Peter Stalmans Leuven, Belgium In view of the high incidence of cataract formation after vitrectomy, a vitrectomy is often combined with a phaco procedure. Several pitfalls in the used phaco-technique must be avoided. The type of the used IOL must also be chosen in function of visualization of the posterior pole during and after the vitrectomy.

Read More
content top